Hamilton Thomas Edward 4
4 · Larimar Therapeutics, Inc. · Filed May 31, 2024
Insider Transaction Report
Form 4
Hamilton Thomas Edward
Director
Transactions
- Purchase
Common Stock
2024-02-16$8.74/sh+57,208$499,998→ 564,798 total - Award
Stock Option (Right to Buy)
2024-05-29+19,000→ 19,000 totalExercise: $7.07Exp: 2034-05-29→ Common Stock (19,000 underlying)
Holdings
- 159,433(indirect: By LLC)
Common Stock
Footnotes (2)
- [F1]Represents shares of common stock purchased in the underwritten offering of Larimar Therapeutics, Inc. (the "Company") at the offering price, which closed on February 16, 2024.
- [F2]The options vest on the earlier of (a) May 29, 2025 or (b) the date of the Company's next annual meeting of stockholders, in each case subject to the Reporting Person's continued service on the Board of Directors of the Company.